Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Pharmacia & Upjohn prepares potent and selective dopamine D4 antagonist

April 29, 1997

SKB reports neuronal calcium channel antagonists

April 29, 1997

Sanofi describes selective NK3 receptor antagonists

April 29, 1997

Delta-opioid agonists/antagonists described by SmithKline Beecham

April 29, 1997

Parke-Davis SAR studies lead to potent, selective D4 antagonist

April 28, 1997

Discovery of potent and selective mu-opiate receptor agonists

April 28, 1997

Mimetix initiates clinical trial with injectable form of naproxen

April 25, 1997

CoCensys discovers potent, water-soluble allosteric modulators of GABA-A receptor

April 25, 1997

Neurotrophic/neuroprotective agents described by Synthelabo

April 25, 1997

Clinical results from international comparative study of olanzapine and haloperidol

April 24, 1997

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...